Literature DB >> 2946651

Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VII. Preparation and NMR characteristics of the aglycone of teicoplanin.

A Malabarba, P Ferrari, G G Gallo, J Kettenring, B Cavalleri.   

Abstract

Several hydrolytic reactions that transform teicoplanin or its pseudo-aglycones into the aglycone with good yields are described. The most interesting approach is hydrolytic removal of the sugars in benzyl alcohol with the formation of the aglycone benzyl ester which is then submitted to hydrogenolysis. A detailed description of the 1H and 13C NMR spectra of the teicoplanin aglycone hydrochloride is presented. All the signals were attributed to the hydrogen and carbon atoms using homo and heteronuclear COSY. The relevant interactions through space between the hydrogen atoms were obtained by NOE. The structural aspects are discussed in terms of the well-known mechanism of action of the glycopeptide antibiotics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2946651     DOI: 10.7164/antibiotics.39.1430

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Crystal structure of a phenol-coupling P450 monooxygenase involved in teicoplanin biosynthesis.

Authors:  Zhi Li; Sanjeewa G Rupasinghe; Mary A Schuler; Satish K Nair
Journal:  Proteins       Date:  2011-03-28

2.  Cloning and characterization of new glycopeptide gene clusters found in an environmental DNA megalibrary.

Authors:  Jacob J Banik; Sean F Brady
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-05       Impact factor: 11.205

3.  Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics.

Authors:  Jan Balzarini; Els Keyaerts; Leen Vijgen; Herman Egberink; Erik De Clercq; Marc Van Ranst; Svetlana S Printsevskaya; Eugenia N Olsufyeva; Svetlana E Solovieva; Maria N Preobrazhenskaya
Journal:  Antiviral Res       Date:  2006-04-06       Impact factor: 5.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.